Lorbrena Now Approved Sites Nov 14, 2018Nov 13, 2018 Brand: Lorbrena (lorlatinib), Tablets Parent Company: Pfizer Drug Type: Prescription Drug Category: Oncology Campaign: now-approved Targeting: HCPs, Patients, Caregivers Patient Website: https://www.lorbrena.com/ HCP Website: https://www.lorbrenahcp.com/ Patient “Now Approved” Page Patient “Now Approved” Page (Mobile) HCP “Now Approved” Page HCP “Now Approved” Page (Mobile)